Naveen Sharma, MD
Cardiology · Ventura, CANPI 1649387499
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,141 of the $11,426 with a category attached, or 71.2%. 34 manufacturers reported payments, led by Angiodynamics, Inc. at 41.3% of the total. Among cardiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $49.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$5K
- Penumbra, Inc.$1K
- Aadi Bioscience, Inc.$800
- Amgen$582
- AstraZeneca$453
- Philips North America LLC$425
- plus $3K from 28 others
What the payments were for
- Consulting fees$8007%
- Travel & lodging$2,47222%
- Food & beverage$8,14171%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 87 | $4,720 |
| Penumbra, Inc. | 4 | $1,031 |
| Aadi Bioscience, Inc. | 1 | $800 |
| Amgen(2 entities) | 14 | $582 |
| AstraZeneca | 9 | $453 |
| Philips North America LLC | 13 | $425 |
| Actelion Pharmaceuticals US, Inc. | 3 | $284 |
| Johnson & Johnson | 15 | $276 |
| Medtronic(2 entities) | 3 | $259 |
| Cardiovascular Systems Inc. | 9 | $255 |
| Edwards Lifesciences | 4 | $249 |
| Pfizer | 5 | $192 |
| Boston Scientific | 7 | $169 |
| AbbVie | 2 | $158 |
| Boehringer Ingelheim | 7 | $152 |
| Smith+Nephew | 2 | $146 |
| Bayer | 3 | $143 |
| Inspire Medical Systems, Inc. | 1 | $137 |
| Cordis US CORP. | 5 | $127 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Novartis | 7 | $114 |
| Organogenesis Inc. | 1 | $114 |
| Novo Nordisk | 5 | $96 |
| E.r. Squibb & Sons, L.L.C. | 5 | $75 |
| Abbott | 3 | $63 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Esperion Therapeutics, Inc. | 2 | $48 |
| Akcea Therapeutics, Inc. | 2 | $46 |
| Terumo Medical Corporation | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Ascensia Diabetes Care US Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Lantheus Medical Imaging, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo$2,299
- AngioVac$1,781
- FYARRO$800
- Auryon Laser System 100-120 Vac$577
- AlphaVac$570
- FARXIGA$375
- KRYSTEXXA$358
- Edwards SAPIEN 3 Transcatheter Heart Valve$198
- Amplia MRI$149
- Inspire$137
- GRAFIX PL$130
- Grafix XC$130
- Stravix$130
- STRAVIX PL$130
- Adempas$125
- NUZYRA$125
- DALVANCE$124
- VYNDAQEL$124
- Diamondback Peripheral$124
- PuraPly$114
How this compares
$11,426 in reported general payments places this provider in the 90th percentile of 156 cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 11 | $5,462 |
| Varenicline Tartrate | 18 | $3,154 |
| ClopidogrelClopidogrel Bisulfate | 290 | $3,008 |
| Rosuvastatin Calcium | 60 | $2,236 |
| Icosapent Ethyl | 11 | $1,785 |
| Pantoprazole Sodium | 80 | $710 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 231 | $384 |
| Ropinirole Hcl | 23 | $315 |
| Doxycycline Hyclate | 52 | $301 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 38 | $272 |
| Gabapentin | 22 | $179 |
| Nitroglycerin | 19 | $130 |
| Cephalexin | 12 | $40 |
| Carvedilol | 12 | $26 |
| Amlodipine Besylate | 17 | $2 |
Paid to pharmacies, not to this prescriber.
Other cardiology in Ventura
- Norman LeporBeverly Hills$1.9M
- Sanjay KaulLos Angeles$1.1M
- Ramtin AgahMountain View$361K
- Jamshid MaddahiLos Angeles$59K
- Bipin JoshiFresno$51K
- Anil ShahSanta Ana$49K
- Thomas KimSanta Ana$47K
- Hooman MadyoonLos Angeles$24K
- Lakhjit SandhuFresno$19K
- Prabhtej BraraSanta Monica$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.